ChemicalBook > CAS DataBase List > Naquotinib (mesylate)

Naquotinib (mesylate)

Product Name
Naquotinib (mesylate)
CAS No.
1448237-05-5
Chemical Name
Naquotinib (mesylate)
Synonyms
ASP8273 (mesylate);Naquotinib (mesylate);Naquotinib mesylate (ASP-8273);Naquotinib mesylate (ASP8273 mesylate);EGFR,ASP8273,ErbB-1,ASP 8273,Inhibitor,Naquotinib mesylate,ASP-8273,HER1,Epidermal growth factor receptor,inhibit,Naquotinib
CBNumber
CB63155066
Molecular Formula
C31H46N8O6S
Formula Weight
658.81194
MOL File
1448237-05-5.mol
More
Less

Naquotinib (mesylate) Property

storage temp. 
Store at -20°C
solubility 
DMSO : 12.5 mg/mL (18.97 mM)
form 
Solid
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-5468
Product name
Naquotinibmesylate
Purity
98.19%
Packaging
5mg
Price
$100
Updated
2021/12/16
ChemScene
Product number
CS-5468
Product name
Naquotinibmesylate
Purity
98.19%
Packaging
10mg
Price
$170
Updated
2021/12/16
ChemScene
Product number
CS-5468
Product name
Naquotinibmesylate
Purity
98.19%
Packaging
25mg
Price
$350
Updated
2021/12/16
ChemScene
Product number
CS-5468
Product name
Naquotinibmesylate
Purity
98.19%
Packaging
50mg
Price
$550
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611426
Product name
Naquotinib mesylate
Packaging
5mg
Price
$569.5
Updated
2021/12/16
More
Less

Naquotinib (mesylate) Chemical Properties,Usage,Production

Uses

Naquotinib mesylate (ASP8273 mesylate) is an orally available, mutant-selective and irreversible EGFR inhibitor; with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR.

in vivo

Oral Naquotinib treatment dose dependently induces tumor regression in NCI-H1975 (L858R/T790M), HCC827 (del ex19) and PC-9 (del ex19) xenograft models. Dosing schedules does not affect the efficacy of Naquotinib. In an NCI-H1975 xenograft model, complete regression of tumor is achieved after 14-days of Naquotinib treatment. Complete regression is maintained in 50% of mice more than 85 days after cessation of Naquotinib treatment[2].

IC 50

EGFRL858R/T790M; EGFRL858R; EGFRExon 19 deletion; EGFRExon 19 deletion/T790M; EGFR: 230 nM (IC50)

References

[1] Sakagami H, et al. ASP8273, a novel mutant-selective irreversible EGFR inhibitor, inhibits growth of non-small cell lung cancer (NSCLC) cells with EGFR activating and T790M resistance mutations. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1728. doi:10.1158/1538-7445.AM2014-1728
[2] Konagai S, et al. ASP8273 selectively inhibits mutant EGFR signal pathway and induces tumor shrinkage in EGFR mutated tumor models. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2586. doi:10.1158/1538-7445.AM2015-2586

Naquotinib (mesylate) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Naquotinib (mesylate) Suppliers

ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai XingMo Biotechnology Co., Ltd.
Tel
+86 13524779951; 13524779951
Fax
QQ: 2075692521
Email
2075692521@qq.com
Country
China
ProdList
301
Advantage
55
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9729
Advantage
58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel
86-571-88216897,88216896 13588875226
Fax
86-571-88216895
Email
sales@hzclap.com
Country
CHINA
ProdList
6312
Advantage
58
Ningbo Haorui Biological Technology Co., Ltd.
Tel
15221000252
Email
278450236@qq.com
Country
China
ProdList
203
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-021-61998551 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9778
Advantage
58
Absin Bioscience Inc.
Tel
021-38015121 18438616290
Email
lanwu@univ-bio.com
Country
China
ProdList
24731
Advantage
58
Ningbo yirui biology science and technology co., ltd
Tel
15221000252
Email
278450236@qq.com
Country
China
ProdList
370
Advantage
58
cjbscvictory
Tel
13348960310
Email
3003867561@qq.com
Country
China
ProdList
10503
Advantage
58
ChemeGen
Tel
18818260767
Fax
QQ 3610331285
Email
2625930290@qq.com
Country
China
ProdList
6973
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
15387063101
Email
2881924050@qq.com
Country
China
ProdList
9957
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12000
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9835
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525 17316404525
Email
209533805@qq.com
Country
China
ProdList
9763
Advantage
58
Adooq Bioscience LLC
Tel
400-025-6535
Email
sales@adooq.cn
Country
China
ProdList
6215
Advantage
58
Shenzhen Zuoke Biotechnology Co., Ltd.
Tel
13532174601
Country
CHINA
ProdList
109
Advantage
58
Guangzhou Baben Biotechnology Co., Ltd.
Tel
17130848100
Country
CHINA
ProdList
143
Advantage
58
Biorbyt Ltd.
Tel
--
Fax
--
Email
info@biorbyt.com
Country
CHINA
ProdList
6482
Advantage
58
Shanghai Qiming Biological Technology Co., Ltd.
Tel
--
Fax
--
Country
CHINA
ProdList
6502
Advantage
58
Shanghai Hao Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
market@xlswkj.com
Country
CHINA
ProdList
6793
Advantage
58
Shanghai Hao Zhun Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
info@zzsrm.com
Country
CHINA
ProdList
6650
Advantage
58

1448237-05-5, Naquotinib (mesylate)Related Search:


  • Naquotinib (mesylate)
  • Naquotinib mesylate (ASP8273 mesylate)
  • ASP8273 (mesylate)
  • EGFR,ASP8273,ErbB-1,ASP 8273,Inhibitor,Naquotinib mesylate,ASP-8273,HER1,Epidermal growth factor receptor,inhibit,Naquotinib
  • Naquotinib mesylate (ASP-8273)
  • 1448237-05-5